Illumina Hits Rival BGI With New DNA Sequencing Patent Suit (1)

Illumina Inc. sued Chinese rival BGI Genomics Co. Thursday in San Francisco federal court, adding a new court fight to a worldwide patent dispute over DNA sequencing products.

The new complaint brought additional claims that BGI infringed three related patents, after the Chinese company recently announced that it would start selling sequencers commercially in the U.S. in April.

Illumina sued BGI for infringing two patents in the same court last year.

Illumina said it is “internationally recognized as the leading supplier of patented DNA sequencing equipment,” and that its products “have been the engine for the biotech revolution, including major ...